Ling‐Ming Tseng

机构：National Yang Ming Chiao Tung University, Taipei Veterans General Hospital, National Defense Medical Center · ORCID：0000-0002-4648-6646

发表论文 385 篇 · 总被引 14389 次 · h-index 54

代表论文

Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort (2025 · Nature Communications · 被引 15)
Comprehensive genomic profiling of Taiwanese triple-negative breast cancer with a large targeted sequencing panel (2025 · Journal of the Chinese Medical Association · 被引 10)
Multi-gene expression assays in breast cancer: a literature review (2025 · Translational Cancer Research · 被引 6)
Impact of PIK3CA Mutations on the Clinical Benefits of CDK 4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer: An Updated Pairwise and Network Meta-Analysis (2025 · Journal of Cancer · 被引 5)
Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: prognostic effect of proton pump inhibitor use (2025 · The Oncologist · 被引 2)
ATP synthasome contributes to efficient energy flux in malignant breast cancer (2026 · Molecular Cancer · 被引 1)